Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Evaluate immunogenicity, safety & reactogenicity of GSK Biologicals' 10-valent pneumococcal conjugate vaccine given as catch-up immunization in children older than 7 mo of age or as 3-dose primary immunization in children before 6 mo of age
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
107058
NCT00345358
Infections, Streptococcal
Phase 3
 
An annotated case report form is not available for this study. A blank case report form will be provided.
September 2013

Powered by ideaPoint, Inc.